Search Results

You searched for : Glucagon  

GLP-1 Receptor Agonists: A New Era in Weight Loss Treatment

Obesity is a complex chronic disease characterized by excessive body fat and is often linked to conditions such as diabetes and hypertension. GLP1 receptor agonists ...
Aug 10

Weight Loss Injections in India: Cost, Safety, and Guide

Weight loss injections offer advanced metabolic support in India, but they require strict medical supervision, significant financial commitment, and permanent lifestyle integration to ensure safe, ...
Jun 09

Why Is My Blood Sugar High in the Morning? Doctor Explains Dawn Phenomenon

Managing morning spikes requires structured monitoring, tracking midnight trends, and identifying lifestyle triggers. By working closely with a doctor to tailor medication timing, optimize evening ...
May 22

Addiction, Appetite, and the Brain: The Science of Craving And the Drug That Might Turn It Down

A medication initially designed to regulate blood sugar eventually transformed the management of obesity. Now it may hold clues to understanding the biological roots of ...
Mar 10

Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ...
Oct 16

Lilly’s oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes

In ACHIEVE-2, orforglipron lowered A1C by up to 1.7% compared to 0.8% with dapagliflozin, meeting the primary endpoint. In ACHIEVE-5, orforglipron ...
Oct 15

The Twin Therapy that Could Help Win India’s Fight Against Diabetes

As India continues its journey towards becoming the diabetes capital of the world, the medical fraternity faces the challenge of changing old habits both in ...
Oct 08

Lilly’s Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease

Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C ...
Aug 01

Wegovy Lands in India: Miracle Weight Loss Shot or Medical Marketing Hype?

As India confronts an alarming rise in obesity and related conditions like type 2 diabetes, cardiovascular disease, and polycystic ovarian syndrome, the spotlight on medical ...
Jun 25

Mounjaro (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of Medicine

...
May 12

The Weight Loss Drug That Could Weigh Down Your Mind: A Closer Look at Ozempic’s Hidden Cost

Ozempic has sparked a conversation that goes beyond pharmacology. It touches on the way we define wellbeing, the pressures we place on our bodies, and ...
Apr 23

Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetes

...
Mar 20

Is Ozempic Truly A ‘Miracle Drug’ For Weight Loss? Understanding The Safety and Effectiveness Concerns

Ozempic is not officially available in India and is not approved for use in India. While the demand for Ozempic is high, the supply is ...
Jan 23

A New Hope for Type 1 Diabetes: Tackling Blood Sugar Drops with Somatostatin Blockers

While it may take time for this new treatment to become widely available, the potential impact on the lives of those with type 1 diabetes ...
Oct 03

Mobile-health Network Solutions [MaNaDr] to Offer GLP-1 Injectables for Medical Weight Loss from USD10/Day

Many weight management solutions available today ultimately fail – partly because patients do not receive the help they need, when they need it....
Jun 20

FDA Approves Zepbound: A New Medication for Weight Loss by Eli Lilly

As the medication becomes available, its impact on individuals suffering from obesity and related conditions is eagerly anticipated. However, the pricing challenges highlight the need ...
Nov 17

Lower your blood sugar naturally

Diabetes occurs when a body is not able to make enough or effectively use insulin, a hormone that helps in regulating blood glucose ...
Jun 19

Xeris Pharmaceuticals receives approval from the European Commission for Ogluo

Ogluo (Glucagon) is indicated treatment of severe hypoglycemia...
Feb 15

FDA Approves First Generic of Drug Used to Treat Severe Hypoglycemia

Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, ...
Dec 29

Pancreatic Cancer Awareness Month

If your pancreas doesn’t produce enough pancreatic enzymes, digesting food especially fat will be difficult for the body. When fat isn’t digested fully, ...
Nov 04

20 Matching result(s) found!

-Advertisements-



Trending Now

Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Vahan.ai Advances Multilingual AI Recruitment with NVIDIA NemotronAugust 25, 2026
Beyond Basic Baby Care: Addressing the Monsoon Surge in Infant Skin Concerns with Salve’s Littloo RangeAugust 25, 2026
100+ Bengaluru Clinics Use QR678® as Indian Hair Regeneration Platform Adds New Patent and Expands GloballyAugust 25, 2026
Healthcare Innovation in India: Real Stories That Are Reshaping the Future of MedicineAugust 25, 2026
Generative AI in Indian Hospitals: Where It Is Actually Making a Difference in 2026August 25, 2026
High Uric Acid and Gout: Symptoms, Causes, Diet, Tests, and Treatment ExplainedAugust 24, 2026
Vitamin D Deficiency in India: Symptoms, Causes, Tests, Treatment and PreventionAugust 24, 2026
SRM College of Pharmacy Hosts Two-Day National Pharmaceutical ConferenceAugust 21, 2026
Atomy India Joins Hands with the Paralympic Committee of India as OfficialNutrition and Wellness PartnerAugust 21, 2026
Thumbay International Pathway - MD Program with Installments and a Direct Route to Residency in RomaniaAugust 21, 2026
THIP wins ‘Breakthrough Digital Patient Education Initiative’ award at India Vaccine Leaders Conclave in PuneAugust 21, 2026
Three Watermelons, a Mannequin Head and a PS5: What India Left Behind on Intercity BusesAugust 21, 2026
Evaluating Thyroid Nodules: Fine Needle Aspiration Cytology (FNAC) and Bethesda ClassificationAugust 21, 2026
Clinical Approaches to Acute Kidney Injury (AKI): Biomarkers, Staging, and Renal Replacement TherapyAugust 21, 2026
Diabetes Care in India: Understanding the Crisis, Bridging the Gaps, and Building a Healthier FutureAugust 21, 2026
Diabetes Management: Lifestyle Changes That Make a Real DifferenceAugust 21, 2026
TagMango introduces New AI capabilities for creator businesses at RISE 2026August 20, 2026
AFib: The Irregular Heartbeat We Need to Stop IgnoringAugust 20, 2026
Nanavati Max Launches Dedicated Cancer Helpline to Support Patients and Families In Their Cancer JourneyAugust 20, 2026